Biolidics Limited

Catalist:8YY Stock Report

Market Cap: S$47.3m

Biolidics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Catalist:8YY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Oct 24BuyS$1,627,626Hua ZhuIndividual407,000,000S$0.004
22 Jan 24SellS$89,996Kong Leong WongIndividual7,500,000S$0.012
11 Jan 24BuyS$1,004,199Chao ZhouIndividual83,000,000S$0.012

Insider Trading Volume

Insider Buying: 8YY insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 8YY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies19,044,6001.13%
Institutions48,232,2302.85%
General Public770,135,90645.5%
Individual Insiders853,346,10050.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 157.1%.

Top Shareholders

Top 14 shareholders own 54.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.9%
Hua Zhu
505,500,000S$14.2m413%no data
9.94%
Kun Wei Wu
168,008,400S$4.7m0%no data
4.91%
Chao Zhou
83,000,000S$2.3m0%no data
2.18%
Kong Leong Wong
36,793,500S$1.0m0%no data
1.53%
Spring Seeds Capital Pte. Ltd.
25,880,800S$724.7k0%100.0%
1.45%
Tang Yih Song
24,501,500S$686.0k0%no data
1.13%
Trauwin Pte Ltd
19,044,600S$533.2k0%no data
0.88%
Futu Holdings Limited, Asset Management Arm
14,884,900S$416.8k0%no data
0.62%
Boon Seong Tok
10,500,000S$294.0k0%no data
0.54%
Ee Lee
9,181,100S$257.1k0%no data
0.44%
Ifast Financial Pte. Ltd., Asset Management Arm
7,466,530S$209.1k0%0.02%
0.43%
Chwee Lim
7,330,600S$205.3k0%no data
0.27%
Beng Choon Tng
4,530,000S$126.8k0%no data
0.24%
Seow Huat Koh
4,001,000S$112.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 23:42
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biolidics Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi Sin NgohCGS International